Humana Inc. (NYSE:HUM) Receives $315.86 Average PT from Analysts

Shares of Humana Inc. (NYSE:HUM - Get Free Report) have received a consensus recommendation of "Hold" from the twenty-five brokerages that are currently covering the company, MarketBeat.com reports. Nineteen research analysts have rated the stock with a hold recommendation and six have assigned a buy recommendation to the company. The average 1-year price target among analysts that have issued ratings on the stock in the last year is $315.86.

Several equities analysts have recently issued reports on HUM shares. JPMorgan Chase & Co. lifted their price objective on shares of Humana from $332.00 to $396.00 and gave the stock a "neutral" rating in a research note on Wednesday, August 21st. Barclays raised their target price on shares of Humana from $250.00 to $253.00 and gave the stock an "equal weight" rating in a report on Thursday, October 31st. Stephens reaffirmed an "equal weight" rating and issued a $250.00 price target on shares of Humana in a report on Wednesday, October 9th. Oppenheimer reduced their price objective on Humana from $400.00 to $280.00 and set an "outperform" rating for the company in a research note on Thursday, October 3rd. Finally, TD Cowen boosted their target price on Humana from $261.00 to $268.00 and gave the stock a "hold" rating in a research report on Monday, November 4th.

Institutional Inflows and Outflows

Hedge funds have recently made changes to their positions in the stock. Continuum Advisory LLC boosted its holdings in shares of Humana by 19,917.6% during the 3rd quarter. Continuum Advisory LLC now owns 13,612 shares of the insurance provider's stock worth $4,311,000 after buying an additional 13,544 shares during the period. LRI Investments LLC boosted its holdings in Humana by 1,021.4% during the third quarter. LRI Investments LLC now owns 157 shares of the insurance provider's stock valued at $50,000 after acquiring an additional 143 shares during the period. Y Intercept Hong Kong Ltd grew its position in shares of Humana by 180.7% in the third quarter. Y Intercept Hong Kong Ltd now owns 5,741 shares of the insurance provider's stock valued at $1,818,000 after purchasing an additional 3,696 shares during the last quarter. MML Investors Services LLC grew its position in shares of Humana by 15.6% in the third quarter. MML Investors Services LLC now owns 4,737 shares of the insurance provider's stock valued at $1,500,000 after purchasing an additional 638 shares during the last quarter. Finally, XTX Topco Ltd bought a new position in shares of Humana in the third quarter worth about $1,727,000. Institutional investors and hedge funds own 92.38% of the company's stock.

Humana Price Performance

HUM traded down $7.47 during trading on Friday, reaching $275.67. The stock had a trading volume of 1,842,901 shares, compared to its average volume of 1,875,008. Humana has a 1-year low of $213.31 and a 1-year high of $527.18. The firm has a market capitalization of $33.19 billion, a price-to-earnings ratio of 24.42, a price-to-earnings-growth ratio of 2.29 and a beta of 0.52. The stock has a 50 day moving average of $281.36 and a two-hundred day moving average of $331.61. The company has a quick ratio of 1.76, a current ratio of 1.76 and a debt-to-equity ratio of 0.67.

Humana (NYSE:HUM - Get Free Report) last announced its quarterly earnings data on Wednesday, October 30th. The insurance provider reported $4.16 earnings per share for the quarter, beating the consensus estimate of $3.48 by $0.68. The business had revenue of $29.30 billion during the quarter, compared to analyst estimates of $28.66 billion. Humana had a return on equity of 13.20% and a net margin of 1.18%. As a group, equities analysts anticipate that Humana will post 15.83 EPS for the current fiscal year.

Humana Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, January 31st. Shareholders of record on Tuesday, December 31st will be given a $0.885 dividend. The ex-dividend date is Tuesday, December 31st. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.28%. Humana's dividend payout ratio is currently 31.36%.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.